Immunogenicity and anti-fecundity effect of nanoparticle coated glutathione S-transferase (SjGST) DNA vaccine against murine Schistosoma japonicum infection.
Immunogenicity and anti-fecundity effect of nanoparticle coated glutathione S-transferase (SjGST) DNA vaccine against murine Schistosoma japonicum infection.
复制标题
纳米颗粒包被的谷胱甘肽 S-转移酶 (SjGST) DNA 疫苗对小鼠日本血吸虫感染的免疫原性和抗生殖作用。
DOI:
10.1016/j.parint.2015.01.005
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Hirayama K.
中科院分区:
文献类型:
--
作者:
Mbanefo EC;Kumagai T;Kodama Y;Kurosaki T;Furushima-Shimogawara R;Cherif MS;Mizukami S;Kikuchi M;Huy NT;Ohta N;Sasaki H;Hirayama K.
There is still urgent need for a vaccine against schistosomiasis, especially inSchistosoma japonicumendemic areas where even a vaccine that will interrupt zoonotic transmission will be potentially effective as an intervention tool. We had developed a novel nanoparticle gene delivery system, which has proven efficacious in gene transfection to target immune cells with complementary adjuvant effect and high protective efficacy in several diseases. Here, we applied this nanoparticle system in combination withS.japonicumglutathione S-transferase (SjGST) DNA vaccine to show the immunogenicity and anti-fecundity effect of the nanoparticle coated vaccine formulation against murine schistosomiasis. The nanoparticle-coated DNA vaccine formulation induced desired immune responses. In comparison with the nanoparticle coated empty vector, it produced significantly increased antigen-specific humoral response, T-helper 1 polarized cytokine environment, higher proportion of IFN-γ producing CD4+T-cells and the concomitant decrease in IL-4 producing CD4+T-cells. Although there was no effect on worm burden, we recorded a marked reduction in tissue egg burden. There was up to 71.3% decrease in tissue egg burden and 55% reduction in the fecundity of female adult worms. Our data showed thatSjGST DNA vaccine, delivered using the nanoparticle gene delivery system, produced anti-fecundity effect on female adult schistosomes as previously described by using conventional subunit vaccine with adjuvant, proving this DNA vaccine formulation as a promising candidate for anti-pathology and transmission blocking application.